Average Co-Inventor Count = 4.15
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Calithera Biosciences, Inc. (8 from 30 patents)
2. Roche Palo Alto LLC (5 from 322 patents)
3. Other (3 from 832,880 patents)
4. Hoffmann-La Roche Inc. (3 from 4,948 patents)
5. Agouron Pharmaceuticals, Inc. (1 from 174 patents)
6. Antengent Therapeutics Limited (1 from 1 patent)
7. Precision Pharmaceuticals, Inc. (1 from 1 patent)
8. Antengene Therapeutics Limited (1 from 1 patent)
9. F. Hoffmann-La Roche Ag (168 patents)
23 patents:
1. 12421273 - Ectonucleotidase inhibitors and methods of use thereof
2. 12054501 - Compositions and methods for inhibiting arginase activity
3. 11858957 - Ectonucleotidase inhibitors and methods of use thereof
4. 11208414 - Ectonucleotidase inhibitors and methods of use thereof
5. 11078228 - Ectonucleotidase inhibitors and methods of use thereof
6. 11034715 - Ectonucleotidase inhibitors and methods of use thereof
7. 11021495 - Compositions and methods for inhibiting arginase activity
8. 10597411 - Compositions and methods for inhibiting arginase activity
9. 10570167 - Ectonucleotidase inhibitors and methods of use thereof
10. 10472364 - Ectonucleotidase inhibitors and methods of use thereof
11. 10287303 - Compositions and methods for inhibiting arginase activity
12. 8940741 - Inhibitors of bruton's tyrosine kinase
13. 8729078 - Inhibitors of bruton's tyrosine kinase
14. 8481540 - Inhibitors of bruton's tyrosine kinase
15. 8361962 - Tricyclic inhibitors of JAK